Cell Cycle Tools: A Portfolio of Kits and Products for Cell Cycle Research

Cancer, the scourge of the 20th century, is in its most basic form the uncontrolled proliferation of invasive cells as a consequence of perturbations in the genetic and biochemical processes of a normal cell cycle. Deciphering the molecular, genetic, biochemical, and physiological aspects of this process in normal and abnormal cells has received much impetus these past two decades, as researchers seek to understand the nature of cancer, apoptosis, cell differentiation, and tissue regeneration.

Written byChristopher Smith
| 7 min read

Register for free to listen to this article
Listen with Speechify
0:00
7:00
Share

Cancer, the scourge of the 20th century, is in its most basic form the uncontrolled proliferation of invasive cells as a consequence of perturbations in the genetic and biochemical processes of a normal cell cycle. Deciphering the molecular, genetic, biochemical, and physiological aspects of this process in normal and abnormal cells has received much impetus these past two decades, as researchers seek to understand the nature of cancer, apoptosis, cell differentiation, and tissue regeneration. All these processes are inherently associated with the cell cycle. In addition, explicitly defining the mechanisms of these diseases and physiological phenomena may provide novel avenues to develop pharmaceuticals and therapies to aid in the treatment of these and other medical maladies such as neurodegenerative and autoimmune diseases.

Thus, some of the most examined aspects of cells have been the events, molecules, and signals controlling the cell cycle. Conceptually, the regulators of this basic activity are ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to digital editions of The Scientist, as well as TS Digest, feature stories, more than 35 years of archives, and much more!
Already a member? Login Here

Meet the Author

Published In

Share
Image of a man in a laboratory looking frustrated with his failed experiment.
February 2026

A Stubborn Gene, a Failed Experiment, and a New Path

When experiments refuse to cooperate, you try again and again. For Rafael Najmanovich, the setbacks ultimately pushed him in a new direction.

View this Issue
Human-Relevant In Vitro Models Enable Predictive Drug Discovery

Advancing Drug Discovery with Complex Human In Vitro Models

Stemcell Technologies
Redefining Immunology Through Advanced Technologies

Redefining Immunology Through Advanced Technologies

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Beckman Coulter Logo
Conceptual multicolored vector image of cancer research, depicting various biomedical approaches to cancer therapy

Maximizing Cancer Research Model Systems

bioxcell

Products

Sino Biological Logo

Sino Biological Pioneers Life Sciences Innovation with High-Quality Bioreagents on Inside Business Today with Bill and Guiliana Rancic

Sino Biological Logo

Sino Biological Expands Research Reagent Portfolio to Support Global Nipah Virus Vaccine and Diagnostic Development

Beckman Coulter

Beckman Coulter Life Sciences Partners with Automata to Accelerate AI-Ready Laboratory Automation

Refeyn logo

Refeyn named in the Sunday Times 100 Tech list of the UK’s fastest-growing technology companies